| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/04/2011 | US20110189267 MULTIPLE CpG OLIGODEOXYNUCLEOTIDE AND THEIR USE TO INDUCE AN IMMUNE RESPONSE |
| 08/04/2011 | US20110189266 Corticosteroid microvesicles for treatment of cardiovascular diseases |
| 08/04/2011 | US20110189265 Therapeutic use of new pharmaceutical preparations containing antitumoral drugs bound to hyaluronic acid in the treatment of neoplasias |
| 08/04/2011 | US20110189264 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof |
| 08/04/2011 | US20110189263 Peptides that target dorsal root ganglion neurons |
| 08/04/2011 | US20110189262 Methods and Compositions for Reducing Systemic Toxicity of Vectors |
| 08/04/2011 | US20110189261 Transdermally absorbable preparation |
| 08/04/2011 | US20110189260 Use of zinc chelators to inhibit biofilm formation |
| 08/04/2011 | US20110189259 Multidirectional mucosal delivery devices and methods of use |
| 08/04/2011 | US20110189257 Nanoparticle based therapy for aggregating mucin |
| 08/04/2011 | US20110189256 Reduction of infection associated with medical device |
| 08/04/2011 | US20110189252 Pharmaceutical compositions comprising lignans and their derivatives for treating hyperplastic diseases |
| 08/04/2011 | US20110189245 Smooth, High Solids Tablet Coating Composition |
| 08/04/2011 | US20110189244 Appetising medicament for oral administration in solid form |
| 08/04/2011 | US20110189243 Pharmaceutical formulation for lowering pulmonary blood pressure |
| 08/04/2011 | US20110189242 Oral galenic form, polymer production method and use of same |
| 08/04/2011 | US20110189241 Process For Controlling The Particle Size of A [3-(Trifluoromethyl)Phenyl]-1-Aminopropane Derivative |
| 08/04/2011 | US20110189240 Microencapsulated compositions for endoluminal tissue engineering |
| 08/04/2011 | US20110189239 Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same |
| 08/04/2011 | US20110189107 Alpha-amylase inhibitors: the montbretins and uses thereof |
| 08/04/2011 | US20110189106 Intranasal compositions, dosage forms and methods of treatment |
| 08/04/2011 | US20110189105 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 08/04/2011 | US20110189104 Surfactant protein d for the treatment of disorders associated with lung injury |
| 08/04/2011 | US20110189103 Aerosolized Fosfomycin/Aminoglycoside Combination for the Treatment of Bacterial Respiratory Infections |
| 08/04/2011 | US20110189092 Polymer-agent conjugates, particles, compositions, and related methods of use |
| 08/04/2011 | US20110189091 Colon lavage system |
| 08/04/2011 | US20110188051 Secure Tracking Of Tablets |
| 08/04/2011 | US20110187015 System and method for uniaxial compression of an article, such as a three dimensionally printed dosage form |
| 08/04/2011 | US20110187012 Automatic multifunctional liposome manufacturing device |
| 08/04/2011 | CA2790146A1 Extruded animal litters having an increased absorption rate |
| 08/04/2011 | CA2788527A1 Pharmaceutical composition for osteoarthritis treatment or prevention and manufacturing method therefor |
| 08/04/2011 | CA2788366A1 Compositions comprising sugar-cysteine products |
| 08/04/2011 | CA2788078A1 Compositions and methods for prevention and treatment of pulmonary hypertension |
| 08/04/2011 | CA2787505A1 Solid pharmaceutical composition with enhancers and methods of preparing thereof |
| 08/04/2011 | CA2787415A1 Dental strip for administration of oral treatment |
| 08/04/2011 | CA2780432A1 Novel polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphthalenyl) ester |
| 08/04/2011 | CA2752473A1 Composition and method for treating ulcers |
| 08/03/2011 | EP2351852A1 RNA interference mediating small RNA molecules |
| 08/03/2011 | EP2351756A1 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof |
| 08/03/2011 | EP2351570A1 An Antibiotic/Analgesic Formulation And a Method of Making This Formulation |
| 08/03/2011 | EP2351567A2 Pharmaceutical composition for prevention and treatment of diabetes or obesity comprising a compound that inhibits activity of dipeptidyl peptidase-iv, and other antidiabetic or antiobesity agents as active ingredients |
| 08/03/2011 | EP2351562A1 Solid solution of valine, isoleucine and leucine, and method for producing same |
| 08/03/2011 | EP2351557A1 Thin film with non-self-aggregating uniform heterogeneity, process for ther production and drug delivery systems made therefrom |
| 08/03/2011 | EP2351556A2 Encapsulated functional fine particle composition capable of spraying and preparation method thereof |
| 08/03/2011 | EP2351555A2 Abuse resistance opioid transdermal delivery device |
| 08/03/2011 | EP2351554A1 Enhanced stability phenylephrine liquid compositions |
| 08/03/2011 | EP2350263A1 Compositions and methods for treating thymic stromal lymphopoietin (tslp)-mediated conditions |
| 08/03/2011 | EP2350109A1 Xylitol esters and ethers applied as alternative emulsifiers, solvents, co-emulsifiers and preservative systems for pharmaceutical and cosmetic products |
| 08/03/2011 | EP2350043A1 Improved amino lipids and methods for the delivery of nucleic acids |
| 08/03/2011 | EP2349981A1 Biocompatible polymers for medical devices |
| 08/03/2011 | EP2349448A1 A transfer device for transferring a substance between the device and a subject |
| 08/03/2011 | EP2349398A2 Drug depot with anchor |
| 08/03/2011 | EP2349345A1 Method for the preparation of a controlled release system |
| 08/03/2011 | EP2349340A2 Stable aqueous formulations of water insoluble or poorly soluble drugs |
| 08/03/2011 | EP2349337A1 Formulations for the treatment of acute herpes zoster pain |
| 08/03/2011 | EP2349336A1 Mesoporous material excipients for poorly aqueous soluble ingredients |
| 08/03/2011 | EP2349314A2 Lyophilized recombinant vwf formulations |
| 08/03/2011 | EP2349309A1 Pyrazalone derivative formulations |
| 08/03/2011 | EP2349302A1 Cardioprotective effects of nutraceuticals isolated from nigella sativa seeds |
| 08/03/2011 | EP2349289A1 Pharmaceutical compositions containing diacerein |
| 08/03/2011 | EP2349285A2 Methods for treating or preventing pain using spicamycin derivatives |
| 08/03/2011 | EP2349282A2 Methods of treating pulmonary disorders with liposomal amikacin formulations |
| 08/03/2011 | EP2349265A1 Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent |
| 08/03/2011 | EP2349258A1 Compositions comprising 4- (2- ( 5-br0m0-4- ( l-cyclopropylnaphthalen-4-yl) -4h-1, 2, 4-triazol-3-ylthio) acetamido -3-chlorobenzoic acid and pharmaceutically acceptable salts thereof |
| 08/03/2011 | EP2349254A2 Skin external composition for inhibiting epidermal hyperproliferation and alleviating inflammatory skin diseases containing ortho-dihydroxyisoflavone derivatives |
| 08/03/2011 | EP2349251A1 Topical formulations with a tertiary amine oxide |
| 08/03/2011 | EP2349250A1 Fatty acids for use as a medicament |
| 08/03/2011 | EP2349249A2 Synergistic composition for recovery and reduction of mild ischemic damage |
| 08/03/2011 | EP2349248A2 Topical nsaid compositions having sensate component |
| 08/03/2011 | EP2349237A2 Curcumin nanoparticles and methods of producing the same |
| 08/03/2011 | EP2349233A1 Use of scyllo-inositols for the treatment of macular degeneration-related disorders |
| 08/03/2011 | EP2349230A2 Amorphous rotigotine transdermal system |
| 08/03/2011 | EP2349229A1 Improved nanoparticulate compositions of poorly soluble compounds |
| 08/03/2011 | EP2349228A1 Iron source product in the form of capsules and process for their preparation |
| 08/03/2011 | EP2349227A2 Alcohol-resistant tablet |
| 08/03/2011 | EP2349226A1 Novel method for preparing granulates of active principles, and granulates obtained thereof |
| 08/03/2011 | EP2349225A1 Microcapsules having an envelope composed essentially of silsesquioxane homopolymers or copolymers |
| 08/03/2011 | EP2349224A1 Orally administrable immunostimulant product for aquaculture |
| 08/03/2011 | EP2349223A2 Dosage units of 3-(6-(1-(2,2-difluorobenzo [d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 08/03/2011 | EP2349222A2 Capsule with soluble blocking element |
| 08/03/2011 | EP2349221A2 Sustained release drug delivery system |
| 08/03/2011 | EP2349220A1 Using of organic solvents in wet granulation of moxifloxacin |
| 08/03/2011 | EP2349219A1 Nanospheres encapsulating bioactive material and method for formulation of nanospheres |
| 08/03/2011 | EP2349218A1 Method for producing controlled-release oral dosage forms |
| 08/03/2011 | EP2349217A1 Novel composition based on gamma-hydroxybutyric acid |
| 08/03/2011 | EP2349216A2 Mouthwash in the form of a stable suspension comprising microspheres that incorporate an active ingredient |
| 08/03/2011 | EP2349215A1 Tablet containing valsartan |
| 08/03/2011 | EP2349214A1 Pharmaceutical composition in granule form and method for the production of such a pharmaceutcal composition |
| 08/03/2011 | EP2349213A1 Phase-separated biocompatible polymer compositions for medical uses |
| 08/03/2011 | EP2349212A1 Mineral-coated microspheres |
| 08/03/2011 | EP2349211A2 Formulations comprising ezetimibe |
| 08/03/2011 | EP2349210A2 Processes and compositions for liposomal and efficient delivery of gene silencing therapeutics |
| 08/03/2011 | EP2349209A2 Nanoemulsion therapeutic compositions and methods of using the same |
| 08/03/2011 | EP2349208A1 Intravaginal delivery system and process for manufacturing it |
| 08/03/2011 | EP2349207A1 Liquid pharmaceutical formulation containing paracetamol |
| 08/03/2011 | EP2349206A2 Corticosteroid compositions and methods of treatments thereof |
| 08/03/2011 | EP2349205A2 Chewable gelled emulsions |
| 08/03/2011 | EP2349204A1 Inhalable particles comprising tiotropium |
| 08/03/2011 | EP2349203A2 Heat sterilised injectable composition of hyaluronic acid or one of the salts thereof, polyols and lidocaine |
| 08/03/2011 | EP2349202A1 Drug delivery systems and methods for treating neovascularization |